Spartalizumab (anti-PD-1) is a human-derived IgG4 antibody against PD-1 that inhibits the binding of PD-L1 and PD-L2 to PD-1. PDR001 binds to PD-1 with high affinity to inhibit its biological activity, MW: 145.8 KD.
Purity:
>99%
CAS Number:
[1935694-88-4]
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted
